HDAC9 and Sepsis: In conclusion, therapeutic targeting of epigenetic regulators in sepsis—including histone acetylation via HDAC inhibition, DNA methylation modulation by DNMT inhibitors, and RNA-based epigenetic therapies—represents a multifaceted approach to restore immune homeostasis, limit organ damage, and improve survival.